Alnylam Pharmaceuticals
ALNY
#869
Rank
HK$229.13 B
Marketcap
HK$1,712
Share price
-0.42%
Change (1 day)
-49.85%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company